August 24, 2026

If methotrexate and TNF blockers haven’t gotten your rheumatoid arthritis under control, or you’re facing giant cell arteritis and want to reduce long-term steroid exposure, your rheumatologist may have prescribed Actemra. It works differently from the biologics most RA patients try first, which is often exactly the point. This guide explains the IL-6 mechanism in […]

Lupus is famously a disease of false alarms: an immune system convinced the body itself is the intruder. For years, the infusion conversation for systemic lupus erythematosus (SLE) centered on Benlysta. Saphnelo, approved in 2021, brought a genuinely different target to the table: the type I interferon pathway, a signaling system that runs hot in